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~ T h e  of Stimulated Acoustic Emission on Impact 
Myocardial Contrast Echoeardlogrephy - Filet 
Clinical Results 
H, Bsoher, K, Tlemsnn, J, K0ster, 1', S(~hlossar, B, Ludsrif~, Oepf, of 
Corrl/ology, University of Bonn, Bonn, Germany 
Previous beth tn.vlfro and animal studies have shown thnt mloro.bubbloa of 
Levovlst ~ sot ae active soun(lsourcea during disintegration es they emit a 
brOad band frequency spectrum (sffmulsfed acousfio emission (SAE)), Due 
to the onset of 8AE It Is possible to receive Doppler.signals oven from station. 
ary bubbles or frOm bubbles with very low flew voloottloa, Honoo, during their 
apeotml cheracforlstlca they a¢~ beyond the wall filter frequencies end have 
o high signet amplitude, However, it Is unknown whether 9A6 ta oppll~eblo 
In humans to display myo~ardlsl contrast effects, Accordingly we evaluated 
myo(~srdlel oenfm~f (MG) offo(:ts in 36 patients with ~orona~ otlaw dis. 
eMe tallowing intravenous boluslnje¢lton of 3g Levovlst, HsrmonlQ Power 
Ooppilr investigations (H.PDI) worn ps~formad using a m0dtlled commer. 
¢islly available uitraaoun~l ms(~htno (HDI 3000, ATL), intermtltent s~anning 
was psrlormed one frame even/fir. (~rdt~c ycle. MC was assessed using 
a four It0p vlsusl score (0 "= nn contrast, 3 ,= complete MC), Contrast effects 
worn ova, lusted using a callbt(1tou soltwsro tool In both myo~Klium and 
cavities, 
Resut~: MC score was t ,6 ~ 0,6 using usual transmit Power (MI 0.8-1) 
a(1d 2,7 • 0,3 with MI =~ t,5 (p - 0,001), Dollneatlon el myocardial contrast 
from contrast signals at the oavlttes was possible while signal Intensities in 
the cavities oven at the endo¢ordlsl border were el least 20 times higher 
than those oi MC, In all registrations contrast signals within the LV.cavlty 
appe~:l at least 5 cycles carter than MC, MC appeared always first in 
ba~t segments of the myecardlum 
Conclusion: H.PDI v,lth high transmit power is useful for assessment el 
SAE, This approach ~m;,rovos MC following iv Iniectton at Lovovist, 
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[ -~ '~ A New T luua  Targeted Ultrasound Contrast Agent, 
MRX408 Improves Visualization and Delineation of 
Left Atrial Appendage Clot With Conventional 
2-dimensional Echocardlography 
M, TRkeuchl, T.P. McCrean/, K. Ogunyanktn, M. Vannan, M. Sl~oahan, 
R, Connolly, A. Santanen, E, Linger, N Pandlen. 7hfts - New Engl Met/Cir, 
Bosfon, MA. USA 
Bac/~nd:  Identification at LA appendage thrombus (LAAT) has important 
I~'~pttcatlons, Despite the utility at transesophagaat echocardiography, mti- 
able re~nttlon of LAAT could be difficult, MRX408, made at lipid coated 
pedlumbutano mtcrobubbies, isa new ultrasound contrast hat targets throm- 
bus. We hypothesized that MRX408 would enhance IAAT signals and permit 
differentiation el clot from adjacent issue. 
Methods: To assess this, we attempted to create in viva LAAT in 8 dogs 
nnd lrnagod the heart with convontlonal 2-D echocardiography at base- 
line, during infusion of a nontargeted contrast, MRXt13 and during tangled 
MRX408. LAAT area and Vtdeotntensily (VI) were blindly analyzed. Presence 
or absence of LAAT was verified postmortem. 
Results: (M ± SD): In 2 ol 8 dogs, there was no contrast enhancement 
of LAA zone and autopsy showed no clot. In the other 6 dogs, there was 
visually apparent contrast enhancement in LAA zone with MRX408 but not 
with MRX113, Autopsy showed LAAT in all 6. VI o1 LAAT in those dogs was 
53,5 ~: 13,9 at baseline, slightly higher with MRX113 (79.7 ~_ 29.5) but was 
much higher with MRX408 (93.9 ~L 34,4, p -._ 0,01 vs baseline, p ... 0.04 
vs MRX 113). The lull extent of LAAT (area, cm2) was evident with MRX408 
(7.40 ± 4.31) when Compared to baseline (3.60 ± 283, p -~ 0~02) and 
MRX113 (4.06 ~ :>.72, p < 0.02). 
Conclusion: MRX408, a thrombus targeting contrast agent, enhances the 
echointensity of LAA clot and demonstrates its extent, It is a premising agent 
for the clinical detection o! LAA clot. 
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~- - ]  Olre©t In viva of  Cavltetlonal Activity Recording= 
Within the Anterior Myocardlum During Intermittent 
end Conventional Hermonld Imaging Following 
Intravenous Ultrasound Contrast 
T. Podor, $, LI ~ ,C. Evorboch, U,11vamllyofNobraska Medical Center; 
Ore,the, Nebraska, USA; ~ Swarfhmore Collage, Swartemore, Pennsy~nta, 
USA 
E~ckgm~md: Invitro studies hove demonstrated that the peak ne~t(ve pros- 
sums (PNP) used for diagnostic ultrasound imaging con produce cavitation 
of porlluort~aroon filled mlcmbubbles, but in wvo demons, .~,,~n of this has 
navar been observed, 
Methoo~: We mess(lind mot moan square eovltohenal ~vity (CA) with a 
20 MHZ single crystal transducer aligned so that its focal iIRrton wag within the 
anterior myo¢ordium of two open chest dogs, The he~tt was simultaneously 
imaged with a 1,7 mngahert= hennonlo transducer using PNP el 0,3,-,0,9 
megapaaoals (MPo) end frame tales (FR) of 43 Her1= (He) !0 H~, and one 
FR ovary one ( 1:1 ) to throe ( 1 ;3) oat~diac o/~las (CC), t:la(;kground sub~ 
ante,or myocardial videointansity (MVI) was meosum¢l off.li~, In t ra~ 
(IV) perlluoro¢[xrb~n exl~)Sed mlcmbubbloa (PCB) were given aa ~r  a 
bolus ((],00~5 mr/ks) or centinuous *nlusion (CI), 
Re.suits: Results am shown ('p < 0.05 compared to all other groups): 
(15-0 0 MPa 
4311e t0He t t  t.3 
CA (mV) 1(1102 t? tO2 21104 2Tt0S  
MVI (uniter 15 t 7 30 t 14 5]' :tte 61 .t ~ '  
CA increased as FR decreased, reaching its maximum at the longest FR 
(1 even/3CC). MVI was directly proportional to CA at 0.9 MPa (r = 0.93, p 
. 0,0001) and 0.5 MPa (r = 0.71; p .- O001), but did not correlate with CA 
when using 0.3 MPa. 
Conclus~n: In wvo ear, alien of PCB occurs in respor-~..,e tod ~  el. 
trasound pressures from commercially available transducem. Lower Fit and 
higher PNP ~ncm~se intramyocardia! CA o1 intravenously injected PCB. and 
may be the mechanism for enhanced myocardial contrast with inten~ittent 
harmonic imaging. 
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~' -~ Myocardial Contrast for  the Echocardlography 
OetecUen of Coronary Artery Disease 
A. Moraes, F. Morced, A.C. Nogueira. M. Casttef, F. Snick. W. Pemira. 
H. Dohmann. Hasp#at Pn>Cardiaco & ECOR Rio de Jane~ro. Brawl 
Background: The accuracy ol intravenous (IV) infusion el a PESDA solution 
(sonicated mixture ol I m120% serum albumin. 12 ml 5% dextrose and 8 ml 
decaffuorobutane gas), associated to newer ultrasound imaging techmques 
to detect coronas/aden/disease (CAD) in humans, has not been evaluated 
in a large series of patients (pts). Accordingly, we assessed the ability of IV 
PESDA to rJmrluce myocardial contrast echocardiography (MCE) pedusion 
defects in pts submitted to coronary aagiography tANG) to investigate CAD. 
Methods: In 92 pts (66 male. 62 ~- 11 years) submitted to ANG, MCE 
with IV PESDA was obtained using different protocols with Second Harmonic 
(SH), Power Harmonic (PH) imaging and tnggering mode ('I'M). ANG was 
normal in 15 pts (Group I), with residual lesion <50% alter repedusion in 15 
pts (Group U) and with obstruction >80% in 62 pts (Group III). To provoke 
a vasodilator response dipyndamole (33 pts) or adenosine (20 pts) were 
used. A homogeneous appearance l contrast enhancement distribution was 
established as normal pedusion pattern (NP), and absence or heterogeneous 
enhancement as a perft,sion defect (PD). 
Results: MCE showed NP in all except one pt in Group I and had a PD in 
100% of pts in Group III (in 5 pts only alter stress with diyndamole (3 pts) or 
adenosine (2 pts)). Group II had NP in 9 pts and a PD was detected in 6 pts. 
Conclusion: A PD observed with MCE at rest or after stress strongly 
correlates with the presence of CAD. and may be used to detect CAD in 
humans. 
